A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL151 in Healthy Volunteers

NCT04557800 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: DNL151
DRUG: Placebo

Sponsor

Denali Therapeutics Inc.